National Survey Reveals Americans Saving $5,000 a Year by Ordering Prescriptions From Canada

2 years ago

93% Say Prescription Drug Costs Are Important to How They'll Vote in the Next Election, Compared to 84% a Year…

Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023

2 years ago

CAMBRIDGE, MA / ACCESSWIRE / October 12, 2023 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host a live…

NanoViricides, Inc. to Present at the Partnership Opportunities in Drug Delivery Conference in Boston on October 16, 2023 at 6:07pm ET

2 years ago

SHELTON, CT / ACCESSWIRE / October 12, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), announces that the Company's President,…

VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting

2 years ago

Approved Merger with Notable Labs and All Other Proposals Merger Expected to Close and Begin Trading as Combined Company Under…

NuGen Medical Appoints Industry Leader Ian Heynen as CEO

2 years ago

Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading…

AlzeCure Presents Clinical Phase II-Data with ACD440 for Neuropathic Ppain at Pain Conference

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / October 12, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

Promore Pharma initiates voluntary liquidation

2 years ago

STOCKHOLM, SE / ACCESSWIRE / October 12, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) STOCKHOLM, October 12, 2023 -- Promore Pharma AB…

Kuros Reports a 150% Increase in Direct MagnetOs Sales in the First Nine Months of 2023 and Announces Changes Within the Executive Management

2 years ago

Ad hoc announcement pursuant to Article 53 of the SIX listing rulesDirect MagnetOs sales grew to CHF 20.4 million in…

Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000

2 years ago

KELOWNA, BC / ACCESSWIRE / October 11, 2023 / Tryp Therapeutics Inc. ("Tryp" or the "Company") (CSE:TRYP), a clinical-stage biotechnology…

NHI Announces Third Quarter 2023 Earnings Release and Conference Call Date

2 years ago

MURFREESBORO, TN / ACCESSWIRE / October 11, 2023 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of…